Shortcut to Body Shortcut to main menu

Find Korean Companies

  • Company
    MTHERA PHARMA Co., Ltd.
  • Business Sector
    MedicineㆍBio
  • Key products and services
    Drug Development: MT101(Parkinson's Disease), MT102(Inflammatory Bowel Disease)
  • Brochure
    [MTHERA] IR DECK 2022_short.pdf [View] [Download]
  • Corporate Video
  • Company Profile
     Company Description/Summary
    
    MTHERAPHARMA Co., Ltd. is a biopharmaceutical company focused on developing innovative multi-target driven-disease modifying therapeutics for chronic incurable diseases.
    We have Symthomics as MTHERA's platform technology to accelerate the discovery of multi-target drug candidates by MTHERA-CODA system (AI-based in silico system) and the most cutting-edge technology of multi-omics integration, systems biology and bioinformatics.
    For therapeutic consistency, we have established CMC technology to satisfy totality of evidence required for the global standard of Regulatory Authorities (FDA & EMA) from raw materials to final product.
    We are pioneering multimodal botanical drugs that simultaneously improve the various causes of disease to address unmet medical needs.
    

Services

Invest Korea provides services support your investment journey.

Find Nearby Invest Korea Offices

Discover nearby offices for conventient access in your area

Go to Overseas Office Site